Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 17

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

High Cannabigerol Hemp Extract Moderates Colitis and Modulates the Microbiome in an Inflammatory Bowel Disease Model

Anderson, Benjamin D., Sepulveda, Diana E., Nachnani, Rahul, Cortez-Resendiz, Alonso, Coates, Matthew D., Beckett, Aviauna, Bisanz, Jordan E., Kellogg, Joshua J., Raup-Konsavage, Wesley M.·2024·The Journal of Pharmacology and Experimental Therapeutics
DOI 10.1124/jpet.124.002204
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1124/jpet.124.002204

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 64

  1. Andou, 2009, Dietary histidine ameliorates murine colitis by inhibition of proinflammatory cytokine production from macrophages, Gastroenterology, 136, 564, 10.1053/j.gastro.2008.09.062 · DOI
  2. Appendino, 2008, Antibacterial cannabinoids from Cannabis sativa: a structure-activity study, J Nat Prod, 71, 1427, 10.1021/np8002673 · DOI · Paper page
  3. Bacalia, 2022, Cannabidiol Decreases Intestinal Inflammation in the Ovariectomized Murine Model of Postmenopause, Biomedicines, 11, 74, 10.3390/biomedicines11010074 · DOI
  4. Baydi, 2021, An update of research animal models of inflammatory bowel disease, The Scientific World Journal, 2021, 10.1155/2021/7479540 · DOI
  5. Bento, 2011, β-Caryophyllene inhibits dextran sulfate sodium-induced colitis in mice through CB2 receptor activation and PPARγ pathway, Am J Pathol, 178, 1153, 10.1016/j.ajpath.2010.11.052 · DOI · Paper page
  6. Blaskovich, 2021, The antimicrobial potential of cannabidiol, Commun Biol, 4, 1, 10.1038/s42003-020-01530-y · DOI · Paper page
  7. Bogale, 2021, Cannabis and Cannabis Derivatives for Abdominal Pain Management in Inflammatory Bowel Disease, Med Cannabis Cannabinoids, 4, 97, 10.1159/000517425 · DOI
  8. Bolyen, 2019, Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2, Nat Biotechnol, 37, 852, 10.1038/s41587-019-0209-9 · DOI · Paper page
  9. Borrelli, 2013, Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease, Biochem Pharmacol, 85, 1306, 10.1016/j.bcp.2013.01.017 · DOI
  10. Callahan, 2016, DADA2: High-resolution sample inference from Illumina amplicon data, Nat Methods, 13, 581, 10.1038/nmeth.3869 · DOI · Paper page
  11. Calvino-Suarez, 2022, Managing ulcerative colitis after surgery, Front Med (Lausanne), 9
  12. Caruso, 2020, Host–microbiota interactions in inflammatory bowel disease, Nature Reviews Immunology, 20, 411, 10.1038/s41577-019-0268-7 · DOI
  13. Chassaing, 2014, Dextran sulfate sodium (DSS)-induced colitis in mice, Current Protocols in Immunology, 104, 15, 10.1002/0471142735.im1525s104 · DOI · Paper page
  14. Chaumeil, 2019, GTDB-Tk: a toolkit to classify genomes with the Genome Taxonomy Database, Bioinformatics, 36, 1925, 10.1093/bioinformatics/btz848 · DOI
  15. Chen, 2016, Asparagine improves intestinal integrity, inhibits TLR4 and NOD signaling, and differently regulates p38 and ERK1/2 signaling in weanling piglets after LPS challenge, Innate Immun, 22, 577, 10.1177/1753425916664124 · DOI
  16. Di Sabatino, 2011, The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease, Mucosal Immunol, 4, 574, 10.1038/mi.2011.18 · DOI
  17. Diab, 2019, Mucosal Metabolomic Profiling and Pathway Analysis Reveal the Metabolic Signature of Ulcerative Colitis, Metabolites, 9, 291, 10.3390/metabo9120291 · DOI
  18. Dutta, 2016, Men and mice: relating their ages, Life sciences, 152, 244, 10.1016/j.lfs.2015.10.025 · DOI · Paper page
  19. Eichele, 2017, Dextran sodium sulfate colitis murine model: An indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis, World Journal of Gastroenterology, 23, 6016, 10.3748/wjg.v23.i33.6016 · DOI
  20. Eisohly, 1982, Synthesis and antimicrobial activities of certain cannabichromene and cannabigerol related compounds, J Pharm Sci, 71, 1319, 10.1002/jps.2600711204 · DOI · Paper page
  21. Farha, 2020, Uncovering the hidden antibiotic potential of cannabis, ACS Infectious Diseases, 6, 338, 10.1021/acsinfecdis.9b00419 · DOI
  22. Fernandes, 2013, ANOVA-like differential expression (ALDEx) analysis for mixed population RNA-Seq, PLoS One, 8, 10.1371/journal.pone.0067019 · DOI
  23. Ghosh, 2022, Cannabinoid CB2 receptors are upregulated via bivalent histone modifications and control primary afferent input to the spinal cord in neuropathic pain, J Biol Chem, 298, 10.1016/j.jbc.2022.101999 · DOI
  24. Glickman, 2023, The Impact of Cannabis Use on Clinical Outcomes in Inflammatory Bowel Disease: A Population-based Longitudinal Cohort Study, Inflamm Bowel Dis, 30, 1055, 10.1093/ibd/izad151 · DOI
  25. Gülck, 2020, Phytocannabinoids: Origins and Biosynthesis, Trends Plant Sci, 25, 985, 10.1016/j.tplants.2020.05.005 · DOI
  26. Hong, 2023, In Vitro and In Vivo Anti-Inflammatory Potential of Cannabichromene Isolated from Hemp, Plants (Basel), 12, 3966
  27. Imdad, 2023, Fecal transplantation for treatment of inflammatory bowel disease, Cochrane Database of Systematic Reviews, 4
  28. Irving, 2018, A Randomized, Double-blind, Placebo-controlled, Parallel-group, Pilot Study of Cannabidiol-rich Botanical Extract in the Symptomatic Treatment of Ulcerative Colitis, Inflamm Bowel Dis, 24, 714, 10.1093/ibd/izy002 · DOI
  29. Izzo, 2012, Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice, Br J Pharmacol, 166, 1444, 10.1111/j.1476-5381.2012.01879.x · DOI
  30. Izzo, 2001, Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation, Br J Pharmacol, 134, 563, 10.1038/sj.bjp.0704293 · DOI
  31. Jamontt, 2010, The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis, Br J Pharmacol, 160, 712, 10.1111/j.1476-5381.2010.00791.x · DOI
  32. Konsavage, 2012, The Myc 3′ Wnt-responsive element regulates homeostasis and regeneration in the mouse intestinal tract, Mol Cell Biol, 32, 3891, 10.1128/MCB.00548-12 · DOI
  33. Konsavage, 2013, The Myc 3′ Wnt responsive element regulates neutrophil recruitment after acute colonic injury in mice, Dig Dis Sci, 58, 2858, 10.1007/s10620-013-2686-x · DOI
  34. Krishnan, 2018, Gut Microbiota-Derived Tryptophan Metabolites Modulate Inflammatory Response in Hepatocytes and Macrophages, Cell Rep, 23, 1099, 10.1016/j.celrep.2018.03.109 · DOI · Paper page
  35. Kuznetsova, 2017, lmerTest Package: Tests in Linear Mixed Effects Models, J Stat Soft, 82, 1, 10.18637/jss.v082.i13 · DOI · Paper page
  36. Liao, 2019, LC-MS-based metabolomics analysis of Berberine treatment in ulcerative colitis rats, J Chromatogr B Analyt Technol Biomed Life Sci, 1133, 10.1016/j.jchromb.2019.121848 · DOI
  37. Liu, 2017, Therapeutic Potential of Amino Acids in Inflammatory Bowel Disease, Nutrients, 9, 920, 10.3390/nu9090920 · DOI
  38. Low, 2013, DNA methylation in inflammatory bowel disease and beyond, World Journal of Gastroenterology: WJG, 19, 5238, 10.3748/wjg.v19.i32.5238 · DOI
  39. Ministro, 2021, Age at diagnosis is determinant for the outcome of inflammatory bowel disease: is it a myth?, Clinical and Translational Gastroenterology, 12, 10.14309/ctg.0000000000000309 · DOI
  40. Nachnani, 2021, The Pharmacological Case for Cannabigerol, J Pharmacol Exp Ther, 376, 204, 10.1124/jpet.120.000340 · DOI
  41. Nachnani, 2023, Chronic Cannabigerol as an Effective Therapeutic for Cisplatin-Induced Neuropathic Pain, Pharmaceuticals (Basel), 16, 1442, 10.3390/ph16101442 · DOI
  42. Naftali, 2013, Cannabis induces a clinical response in patients with Crohn's disease: a prospective placebo-controlled study, Clin Gastroenterol Hepatol, 11, 10.1016/j.cgh.2013.04.034 · DOI
  43. Naftali, 2017, Low-Dose Cannabidiol Is Safe but Not Effective in the Treatment for Crohn's Disease, a Randomized Controlled Trial, Dig Dis Sci, 62, 1615, 10.1007/s10620-017-4540-z · DOI
  44. Pagano, 2016, An Orally Active Cannabis Extract with High Content in Cannabidiol attenuates Chemically-induced Intestinal Inflammation and Hypermotility in the Mouse, Front Pharmacol, 7, 341, 10.3389/fphar.2016.00341 · DOI
  45. Pang, 2021, MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights, Nucleic Acids Res, 49, 10.1093/nar/gkab382 · DOI
  46. Poyet, 2019, A library of human gut bacterial isolates paired with longitudinal multiomics data enables mechanistic microbiome research, Nat Med, 25, 1442, 10.1038/s41591-019-0559-3 · DOI
  47. Quast, 2013, The SILVA ribosomal RNA gene database project: improved data processing and web-based tools, Nucleic Acids Res, 41
  48. Raup-Konsavage, 2016, A Role for MYC in Lithium-Stimulated Repair of the Colonic Epithelium After DSS-Induced Damage in Mice, Dig Dis Sci, 61, 410, 10.1007/s10620-015-3852-0 · DOI
  49. Raup-Konsavage, 2024, Antinociceptive Effects of Cannabichromene (CBC) in Mice: Insights from von Frey, Tail-Flick, Formalin, and Acetone Tests, Biomedicines, 12, 83, 10.3390/biomedicines12010083 · DOI
  50. Romano, 2013, The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis, Br J Pharmacol, 169, 213, 10.1111/bph.12120 · DOI
  51. Sepulveda, 2022, Cannabigerol (CBG) attenuates mechanical hypersensitivity elicited by chemotherapy-induced peripheral neuropathy, Eur J Pain, 26, 1950, 10.1002/ejp.2016 · DOI
  52. Sepulveda, 2022, Combinations of Cannabidiol and Δ 9-Tetrahydrocannabinol in Reducing Chemotherapeutic Induced Neuropathic Pain, Biomedicines, 10, 2548, 10.3390/biomedicines10102548 · DOI
  53. Shah, 2023, The Hitchhiker’s Guide to Statistical Analysis of Feature-based Molecular Networks from Non-Targeted Metabolomics Data, ChemRxiv.
  54. Sleiman, 2022, Medical Treatment Options for Ulcerative Colitis, Clin Colon Rectal Surg, 35, 428, 10.1055/s-0042-1758048 · DOI
  55. Sprouffske, 2016, Growthcurver: an R package for obtaining interpretable metrics from microbial growth curves, BMC Bioinformatics, 17, 172, 10.1186/s12859-016-1016-7 · DOI
  56. Storr, 2014, Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn's disease, Inflamm Bowel Dis, 20, 472, 10.1097/01.MIB.0000440982.79036.d6 · DOI
  57. Sun, 2024, Dietary Cannabidiol Activates PKA/AMPK Signaling and Attenuates Chronic Inflammation and Leaky Gut in DSS-Induced Colitis Mice, Mol Nutr Food Res, 68, 10.1002/mnfr.202300446 · DOI
  58. Tang, 2020, Integrated study of metabolomics and gut metabolic activity from ulcerative colitis to colorectal cancer: The combined action of disordered gut microbiota and linoleic acid metabolic pathway might fuel cancer, J Chromatogr A, 1629, 10.1016/j.chroma.2020.461503 · DOI
  59. Tavakoli, 2021, A Review of Inflammatory Bowel Disease: A Model of Microbial, Immune and Neuropsychological Integration, Public Health Rev, 42, 10.3389/phrs.2021.1603990 · DOI
  60. Ward, 2014, Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT(1A) receptors without diminishing nervous system function or chemotherapy efficacy, Br J Pharmacol, 171, 636, 10.1111/bph.12439 · DOI
  61. Wirtz, 2007, Mouse models of inflammatory bowel disease, Advanced Drug Delivery Reviews, 59, 1073, 10.1016/j.addr.2007.07.003 · DOI · Paper page
  62. Yu, 2018, Two Methods for Mapping and Visualizing Associated Data on Phylogeny Using Ggtree, Mol Biol Evol, 35, 3041, 10.1093/molbev/msy194 · DOI · Paper page
  63. Yu, 2019, Mass spectrometry-based metabolomics for irritable bowel syndrome biomarkers, Therap Adv Gastroenterol, 12, 10.1177/1756284819886425 · DOI
  64. Zhang, 2024, Integrated Metabolomics and Gut Microbiome Analysis Reveals the Efficacy of a Phytochemical Constituent in the Management of Ulcerative Colitis, Mol Nutr Food Res, 68, 10.1002/mnfr.202200578 · DOI

Cited by

See all 17

Metadata

Authors
Anderson, B. D., Sepulveda, D. E., Nachnani, R., Cortez-Resendiz, A., Coates, M. D., Beckett, A., Bisanz, J. E., Kellogg, J. J., & Raup-Konsavage, W. M.
ORCID
Raup-Konsavage, Wesley M.
Venue
The Journal of Pharmacology and Experimental Therapeutics
Publisher
Elsevier BV
Published
2024-09
Volume
390
Issue
3
Pages
331-341
ISSN
0022-3565
DOI
10.1124/jpet.124.002204
Cited by
17
References
3
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: High Cannabigerol Hemp Extract Moderates Colitis and Modulates the Microbiome in an Inflammatory Bowel Disease Model. https://app.cochat.ai/papers/10.1124/jpet.124.002204
The paper
Anderson, B. D., Sepulveda, D. E., Nachnani, R., Cortez-Resendiz, A., Coates, M. D., Beckett, A., Bisanz, J. E., Kellogg, J. J., & Raup-Konsavage, W. M. (2024). High Cannabigerol Hemp Extract Moderates Colitis and Modulates the Microbiome in an Inflammatory Bowel Disease Model. The Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1124/jpet.124.002204

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.